13F HOLDINGS REPORT
Vivo Capital, LLC
Quarter ended Q1 2025 · Filed May 12, 2025 · Accession 0001213900-25-041737
Total Value
$755.1M
Positions
40
Other Managers
0
Confidential Omitted
No
Holdings (40)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Soleno Therapeutics Inc | SLNO | 4,458,294 | $318.5M | 42.19% |
| 2 | Verona Pharma PLC | 925050106 | 1,438,785 | $91.3M | 12.10% |
| 3 | Geron Corp | GERN | 27,225,292 | $43.3M | 5.73% |
| 4 | Trevi Therapeutics Inc | TRVI | 3,487,903 | $21.9M | 2.91% |
| 5 | Avadel Pharmaceuticals PLC | G29687103 | 2,684,109 | $21.0M | 2.78% |
| 6 | Terns Pharmaceuticals Inc | TERN | 6,895,746 | $19.0M | 2.52% |
| 7 | Cidara Therapeutics, Inc. | 171757206 | 684,276 | $14.7M | 1.95% |
| 8 | Aclaris Therapeutics, Inc. | ACRS | 8,888,888 | $13.6M | 1.80% |
| 9 | Viridian Therapeutics Inc | VRDN | 982,576 | $13.2M | 1.75% |
| 10 | Dyne Therapeutics Inc | DYN | 1,114,960 | $11.7M | 1.54% |
| 11 | Oric Pharmaceuticals Inc | ORIC | 2,080,450 | $11.6M | 1.54% |
| 12 | Instil Bio Inc | TIL | 585,485 | $10.2M | 1.35% |
| 13 | Compass Pathway PLC | CMPS | 3,362,385 | $9.6M | 1.27% |
| 14 | Delcath Systems, Inc. | DCTH | 750,195 | $9.5M | 1.26% |
| 15 | Zenas Biopharma Inc | ZBIO | 1,183,260 | $9.3M | 1.24% |
| 16 | Verastem Inc | VSTM | 1,538,461 | $9.3M | 1.23% |
| 17 | Erasca Inc | ERAS | 6,756,756 | $9.3M | 1.23% |
| 18 | Bright Minds Biosciences Inc | DRUG | 251,572 | $9.1M | 1.20% |
| 19 | Tourmaline Bio Inc. | 89157D105 | 591,882 | $9.0M | 1.19% |
| 20 | Abeona Therapeutics, Inc. | ABEO | 1,842,751 | $8.8M | 1.16% |
| 21 | Astria Therapeutics Inc | 04635X102 | 1,552,685 | $8.3M | 1.10% |
| 22 | Akero Therapeutics Inc | 00973Y108 | 201,168 | $8.1M | 1.08% |
| 23 | Corvus Pharmaceuticals Holdings | CRVS | 2,234,566 | $7.1M | 0.94% |
| 24 | Compass Therapeutics Inc | CMPX | 3,556,023 | $6.8M | 0.89% |
| 25 | IO Biotech Inc | IOBT | 6,173,439 | $6.7M | 0.89% |
| 26 | Cogent Biosciences Inc | COGT | 1,122,471 | $6.7M | 0.89% |
| 27 | Unicycive Therapeutics | UNCY | 11,370,152 | $6.5M | 0.87% |
| 28 | Celcuity Inc | CELC | 610,500 | $6.2M | 0.82% |
| 29 | Rezolute Inc | RZLT | 2,112,432 | $6.1M | 0.81% |
| 30 | Sera Prognostics Inc | SERA | 1,650,440 | $6.1M | 0.80% |
| 31 | Olema Pharmaceuticals Inc | OLMA | 1,505,862 | $5.7M | 0.75% |
| 32 | Regulus Therapeutics Inc | 75915K309 | 2,696,426 | $4.7M | 0.62% |
| 33 | Silence Therapeutics PLC | SLNCF | 1,105,454 | $3.1M | 0.41% |
| 34 | Surrozen Inc | SRZNW | 260,000 | $3.0M | 0.40% |
| 35 | 89Bio Inc | 282559103 | 376,804 | $2.7M | 0.36% |
| 36 | Bolt Therapeutics Inc | BOLT | 3,521,291 | $1.4M | 0.19% |
| 37 | Tenax Therapeutics Inc | TENX | 208,333 | $1.4M | 0.18% |
| 38 | Allakos Inc | 01671P100 | 765,500 | $174,228 | 0.02% |
| 39 | Aligos Therapeutics Inc | ALGS | 10,199 | $84,142 | 0.01% |
| 40 | Precision Biosciences Inc | DTIL | 4,675 | $22,301 | 0.00% |